GammaTile delivery of radiation promising for control of Glioblastoma

Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit - Enrolling More Patients

Can CAR T Cell Therapy improve outcomes in Pancreatic, GI, Ovary and other "Solid Tumors"

Is it time to perform NGS testing for all brain tumors?

Dr. Lakshmi Nayak, MD, Dana-Farber Cancer Inst answers questions about brain cancer and its treatment.

Temodar and Hypofractionated Radiotherapy Appropriate for Elderly Patients with Glioblastoma

Research Breakthrough - Activating the brain's immune system against cancer prevents it from spreading .

Gene Test Identifies Patients with Glioblastoma who Achieve Improved Survival with Temodar®

Enzastaurin trial begins and other recent developments for treating Glioblastoma.

Dr. Dudocia Lee M.D. of Dana-Farber Cancer Institute discusses treatment of primary and metastatic brain tumors.

WP1066 for glioblastoma gets FDA orphan drug designation-Approvals in Nov 2020 for pediatric brain tumors.

Opdivo does not improve survival when used to treat recurrent Glioblastoma - but could it work in selected patients?

Regulatable gene therapy encouraging in Glioblastoma Mulitforme

“This is an exciting time in brain tumor research,” says Harriet Patterson, MPH.

FDA Grants Orphan Drug Designation to Zotiraciclib for Glioma

Pivotal clinical trial fails to confirm benefit of 511 & Toca FC in recurrent High-Grade Glioma.

Optune moderately improves the outcomes of patients with Glioblastoma Multiforme.

Research suggest immunotherapy may be effective treatment for glioblastoma.

Stay Current With Brain Cancer Treatment Advances & Connect with Others

Selinexor is a Selective Inhibitor of Nuclear Export (SINE) compound being evaluated in lymphoma, GBM, and solid tumors.

Addition of Temodar® to Radiation in Glioma: New Standard of Care

With advances in personalized medicine, the look and feel of cancer treatment may change dramatically.

CancerConnect - Treatment & Management of Brain Cancer

Dr. Juan Fueyo, MD, of MD Anderson Cancer ha published results of a clinical trial using the common Adenovirus

Alternative Approach to Brain Mapping Preserves Language Function

Cell Phone Use Does Not Increase Risk of Developing Meningioma Brain Cancer

Mixed Outcomes for Radiosurgery in Brain Tumors

Cell Phone Use Not Associated with Increased Risk of Low-Grade Gliomas

Brain Tumor Advocacy Groups

Kimberly Fowler: Brain Cancer Survivor.

Data Safety and Monitoring Board Recommends Celldex’s Study of RINTEGA® in Newly Diagnosed Glioblastoma Be Discontinued

Could the Poliovirus be The Next Breakthrough for the Treatment of Brain Cancers?

MD Anderson Researchers Show Risks of Whole Brain Radiation Therapy Added to Radiosurgery Outweigh Benefits In Patients

UAB first in U.S. to use HyperArc High-Definition Radiotherapy on brain cancer

DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial.

Researchers Recruit Herpes Virus as Part of Brain Cancer Treatment.

Chemotherapy Following Radiation Improves Outcomes in Low Grade Glioblastoma.

Danish Study Suggests Contraceptive Use Increases Risk of Brain Cancer.

Glioblastoma is a particularly aggressive type of brain cancer.

Danish Study Finds No Link Between Cell Phones and Brain Tumors

Follow-Up Study Shows ICT-107 Vaccine Fails to Extend Survival in GBM.

Longer Life for Brain Cancer Patients Who Exercise

Allergies Linked with Lower Risk of Brain Tumor

Avastin Doesn’t Improve Survival in Newly Diagnosed Glioblastoma.

Combination of Radiation and Chemotherapy Improves Survival For Certain Types of Brain Cancer

Children & adolescents who regularly use cell phones do not appear to have a higher risk of brain cancer than non-users.

Repeated Surgeries Improve Survival in Glioblastoma

Glioblastoma Multiforme (GBM) is a devastating disease